Zhuo Chen

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Venues

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Huan He, Xingsen Zhang, Jie Wang, Qi Liu, LeiHao Zhang, Lu Chen, Yuan Yuan, Zhenjiang Zhao, Honglin Li, Zhuo Chen
Development of Degraders of Cyclin-Dependent Kinases 4 and 6 Based on Rational Drug Design. Journal of medicinal chemistry 67 (13) (2024)
Huan He, Xingsen Zhang, Jie Wang, Qi Liu, LeiHao Zhang, Lu Chen, Yuan Yuan, Zhenjiang Zhao, Honglin Li, Zhuo Chen
Development of Degraders of Cyclin-Dependent Kinases 4 and 6 Based on Rational Drug Design. Journal of medicinal chemistry (2024)
Huan He, Xingsen Zhang, Jie Wang, Qi Liu, LeiHao Zhang, Lu Chen, Yuan Yuan, Zhenjiang Zhao, Honglin Li, Zhuo Chen
Development of Degraders of Cyclin-Dependent Kinases 4 and 6 Based on Rational Drug Design. Journal of medicinal chemistry 67 (13) (2024)
Dou Dou, Yanyan Diao, Wenjie Sha, Rongrong Su, Linjiang Tong, Wenjie Li, Limin Leng, Lijuan Xie, Zhixiao Yu, Haoming Song, Zihao Shen, Lili Zhu, Zhenjiang Zhao, Hua Xie, Zhuo Chen, HongLin Li, Yufang Xu
Discovery of Pteridine-7(8 H )-one Derivatives as Potent and Selective Inhibitors of Bruton's Tyrosine Kinase (BTK). Journal of medicinal chemistry 65 (3) (2022)
Yuan Yuan, Junpeng Xu, Lei Jiang, Kangjie Yu, Yuanyuan Ge, Mingyang Li, Huan He, Qiqi Niu, Xiayu Shi, Linni Fan, Zhuo Chen, Zhenjiang Zhao, Shiliang Li, Yufang Xu, Zhe Wang, HongLin Li
Discovery, Optimization, and Structure-Activity Relationship Study of Novel and Potent RSK4 Inhibitors as Promising Agents for the Treatment of Esophageal Squamous Cell Carcinoma. Journal of medicinal chemistry 64 (18) (2021)

Zhuo Chen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zhuo Chen